Skip to main content
Ingersoll Rand Inc. (IR)
Manufacturing Industrial Goods
Stock AI

Ingersoll Rand Announces Participation in 44th Annual J.P. Morgan Healthcare Conference

Last updated: December 22, 2025
Taurigo

1. Key Details of the Announcement

Ingersoll Rand Inc. (NYSE: IR), a leader in the provision of mission-critical flow creation and life science solutions, has announced its participation in the upcoming 44th Annual J.P. Morgan Healthcare Conference. The event is scheduled for January 14, 2026, at 7:30 a.m. Pacific Time. The company’s presentation will feature Vicente Reynal, the chairman and chief executive officer, alongside Vik Kini, the chief financial officer, and Scott Watson, the senior vice president and general manager of Life Science Technologies.

2. Event Accessibility

Investors and interested parties can access a real-time audio webcast of the fireside chat through the Events and Presentations section of Ingersoll Rand's Investor Relations website. Following the live discussion, a replay will also be made available on the same platform, allowing stakeholders to stay informed about the company’s insights and strategic direction.

3. Company Overview

Ingersoll Rand Inc. embodies an entrepreneurial spirit and an ownership mindset, committed to enhancing the lives of its employees, customers, shareholders, and the planet. The company's reputation for exceptional performance and durability in mission-critical flow creation and life science and industrial solutions is supported by a portfolio of over 80 respected brands. Ingersoll Rand’s products and services are designed to thrive in the most challenging conditions, ensuring that customers can rely on them for their critical operations. The dedication of its workforce further solidifies long-term relationships with customers through a relentless commitment to expertise, productivity, and efficiency.

4. Looking Ahead

As Ingersoll Rand prepares for its presentation at the J.P. Morgan Healthcare Conference, stakeholders are eager to hear the insights from its leadership team on the company’s strategies and outlook for the future. This event not only provides a platform for Ingersoll Rand to showcase its innovations and advancements but also emphasizes its ongoing commitment to addressing the needs of the life sciences sector.

Ingersoll Rand’s participation in this prestigious conference underscores its role as a key player in the healthcare and industrial sectors, and investors are advised to tune in for what promises to be an enlightening discussion.

For more information about Ingersoll Rand and to access the webcast, interested individuals can visit the company’s Investor Relations website.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.